Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Total Debt: 2009-2024

Historic Total Debt for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Dec 2024 value amounting to $385.0 million.

  • Ironwood Pharmaceuticals' Total Debt rose 46.13% to $584.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 7.75%. This contributed to the annual value of $385.0 million for FY2024, which is 22.93% down from last year.
  • Ironwood Pharmaceuticals' Total Debt amounted to $385.0 million in FY2024, which was down 22.93% from $499.6 million recorded in FY2023.
  • Ironwood Pharmaceuticals' Total Debt's 5-year high stood at $499.6 million during FY2023, with a 5-year trough of $116.9 million in FY2021.
  • Over the past 2 years, Ironwood Pharmaceuticals' median Total Debt value was $442.3 million (recorded in 2023), while the average stood at $442.3 million.
  • Data for Ironwood Pharmaceuticals' Total Debt shows a maximum YoY fell of 22.93% (in 2024) over the last 5 years.
  • Over the past 3 years, Ironwood Pharmaceuticals' Total Debt (Yearly) stood at $116.9 million in 2021, then reached $499.6 million in 2023, then dropped by 22.93% to $385.0 million in 2024.